You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Target radionuclide therapy

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Neuroendocrine Tumors, Peptide Receptor Radionuclide Therapy Trial in Rotterdam (olaparib)

Recruiting
  • Neuroendocrine Tumors
  • Peptide Receptor Radionuclide Therapy
  • Rotterdam, South Holland, Netherlands
    Erasmus MC
May 19, 2023

Prostate-Specific Membrane Antigen (PSMA) Radionuclide Therapy

Recruiting
  • PSMA-positive Metastatic Castration-resistant Prostate Cancer Treated With PSMA Radionuclide Therapy
  • PSMA radionuclide therapy
  • Dallas, Texas
    Methodist Dallas Medical Center
Aug 9, 2023

Neuroendocrine Tumors, Paraganglioma, Pheochromocytoma Trial (177Lu-DOTATOC)

Not yet recruiting
  • Neuroendocrine Tumors
  • +2 more
  • (no location specified)
Sep 13, 2023

Metastatic Clear Cell Renal Cell Carcinoma, With Positive PSMA Expression at Tumor Sites Trial (177Lu-PSMA-1

Not yet recruiting
  • Metastatic Clear Cell Renal Cell Carcinoma
  • With Positive PSMA Expression at Tumor Sites
  • 177Lu-PSMA-1 (radiopharmaceutical)
  • (no location specified)
Sep 26, 2023

Prostatic Tumors, Castration-Resistant Trial in Rotterdam (Radionuclide Therapy)

Recruiting
  • Prostatic Neoplasms, Castration-Resistant
  • Radionuclide Therapy
  • Rotterdam, Zuid-Holland, Netherlands
    Erasmus Medical Center
Jun 5, 2023

Advanced Malignant Tumor Trial in Beijing ([ Lu-177]-Catalase)

Recruiting
  • Advanced Malignant Neoplasm
  • [ Lu-177]-Catalase
  • Beijing, Beijing, China
    Zhi Yang
Aug 2, 2023

AminoMedixTM for Kidney Protection During Radionuclide Therapy

Completed
  • Radiation Nephropathy
    • (no location specified)
    Mar 22, 2023

    Thyroid Disease Trial in Syracuse (SPECT)

    Enrolling by invitation
    • Thyroid Disease
    • SPECT
    • Syracuse, New York
      SUNY Upstate Medical University
    Aug 31, 2023

    Metastatic Malignant Tumor in the Liver, Neuroendocrine Tumor Trial in San Francisco (procedure, biological, device)

    Recruiting
    • Metastatic Malignant Neoplasm in the Liver
    • Neuroendocrine Neoplasm
    • Arterial Embolization
    • +3 more
    • San Francisco, California
      University of California, San Francisco
    Dec 22, 2022

    Bronchial and Thymic Neuroendocrine Tumour, Paraganglioma/ Phaeochromocytoma, Medullary Thyroid Carcinoma Trial (Lu-177 DOTATATE

    Not yet recruiting
    • Bronchial and Thymic Neuroendocrine Tumour
    • +3 more
    • Lu-177 DOTATATE (Lutathera®)
    • (no location specified)
    Nov 1, 2023

    Neuroendocrine Tumors Trial (Lutathera)

    Not yet recruiting
    • Neuroendocrine Tumors
    • (no location specified)
    Aug 23, 2022

    Prostate Cancer Metastatic Trial in New York (Actinium-J591, Stereotactic Body Radiation Therapy, Androgen Deprivation Therapy)

    Not yet recruiting
    • Prostate Cancer Metastatic
    • New York, New York
      Weill Cornell Medicine - New York Presbyterian Hospital
    Oct 3, 2022

    Nasopharyngeal Carcinoma Trial in Xiamen (177Lu-EB-LM3 1, 177Lu-EB-LM3 2)

    Recruiting
    • SSTR2-positive Tumors
    • 177Lu-LNC1010 1
    • +2 more
    • Xiamen, China
      The First Affiliated Hospital of Xiamen University
    Nov 20, 2022

    Digestive System Neuroendocrine Tumor G1, Digestive System Neuroendocrine Tumor G2, Metastatic Digestive System Neuroendocrine

    Not yet recruiting
    • Digestive System Neuroendocrine Tumor G1
    • +5 more
    • Tumor Debulking
    • +5 more
    • Nashville, Tennessee
      Vanderbilt University/Ingram Cancer Center
    Aug 23, 2023

    Neuroendocrine Tumors, Hyperthyroidism, Thyroid Cancer Trial in London (Nuclear Medicine whole-body, SPECT/CT imaging., PET/CT

    Recruiting
    • Neuroendocrine Tumors
    • +3 more
    • Nuclear Medicine whole-body
    • +4 more
    • London, United Kingdom
      Guy's and St Thomas Hospitals Foundation Trust
    Jan 5, 2022

    Pancreatic Neuroendocrine Tumor, Pancreas Cancer Trial in Chicago (cytoreductive surgery, Lutathera - a small molecule used in

    Not yet recruiting
    • Pancreatic Neuroendocrine Tumor
    • Pancreas Cancer
    • cytoreductive surgery
    • +2 more
    • Chicago, Illinois
      The University of Chicago
    Nov 8, 2022

    Merkel Cell Carcinoma Trial (Pembrolizumab, Lutetium Lu 177 dotatate)

    Not yet recruiting
    • Merkel Cell Carcinoma
    • (no location specified)
    Oct 12, 2022

    Lupus Nephritis, Remission, Safety Issues Trial in Nanjing (Methylprednisolone Injectable Suspension, Belimumab Injection,

    Recruiting
    • Lupus Nephritis
    • +2 more
    • Methylprednisolone Injectable Suspension
    • +2 more
    • Nanjing, Jiangsu, China
      Jiong Zhang
    May 8, 2023

    HRQoL During PRRT in Patients With NETs

    Completed
    • Neuroendocrine Tumors
    • +2 more
      • (no location specified)
      Jun 16, 2022

      Target Therapy for Brain Metastases With EGFR Mutation

      Not yet recruiting
      • Brain Metastases
      • Surgery or Radiotherapy
      • before or after target therapy
      • (no location specified)
      Nov 8, 2022

      Hand-Foot Syndrome Trial (acupuncture, laser acupuncture, Sham-laser acupuncture)

      Not yet recruiting
      • Hand-Foot Syndrome
      • acupuncture
      • +2 more
      • (no location specified)
      Jul 9, 2023

      Solid Tumor, Unspecified, Adult Trial in Singapore (177Lu-LNC1004 Injection group 1 radionuclide therapy, 177Lu-LNC1004

      Not yet recruiting
      • Solid Tumor, Unspecified, Adult
      • 177Lu-LNC1004 Injection group 1 radionuclide therapy
      • +3 more
      • Singapore, Singapore
        National University Cancer Institute, Singapore National Univers
      Feb 1, 2023

      Hepatocellular Carcinoma Trial in Birmingham ([68Ga]DOTATATE-PET/MRI)

      Completed
      Has Results
      • Hepatocellular Carcinoma
      • Birmingham, Alabama
        University of Alabama at Birmingham Medical Center
      Dec 16, 2022

      Recurrent B Acute Lymphoblastic Leukemia, Recurrent B-Cell Non-Hodgkin Lymphoma, Refractory B Acute Lymphoblastic Leukemia Trial

      Not yet recruiting
      • Recurrent B Acute Lymphoblastic Leukemia
      • +5 more
      • Interferon Beta-1A
      • +10 more
      • Seattle, Washington
        Fred Hutch/University of Washington Cancer Consortium
      Jul 6, 2023

      Pancreatic Neuroendocrine Tumor Trial in Milano (peptide receptor radionuclide therapy with Y-90-DOTATOC)

      Recruiting
      • Pancreatic Neuroendocrine Tumor
      • peptide receptor radionuclide therapy with Y-90-DOTATOC
      • Milano, Italy
      • +1 more
      Sep 30, 2022